Isosorbide dinitrate in acute and chronic heart failure

Area of Science:

• Cardiology
• Pharmacology

Background:

• Congestive heart failure (CHF) is a complex syndrome characterized by impaired cardiac function.
• Effective management of CHF requires interventions that improve hemodynamic parameters.

Purpose of the Study:

• To investigate the acute hemodynamic effects of sublingual isosorbide dinitrate (ISD) in patients with congestive heart failure.
• To determine the duration and magnitude of ISD's impact on key hemodynamic markers.

Main Methods:

• A study involving 12 patients with varying etiologies and durations of CHF.
• Serial hemodynamic measurements were taken before and up to 120 minutes after sublingual administration of 5-15 mg ISD.
• Key parameters assessed included mean arterial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, and stroke work index.

Main Results:

• Sublingual ISD demonstrated significant reductions in mean arterial pressure (-7%), mean pulmonary artery pressure (-17%), and mean pulmonary capillary wedge pressure (-29%).
• These hemodynamic improvements were most pronounced at 45 minutes post-administration and returned to baseline levels within 120 minutes.
• No significant changes were observed in heart rate, cardiac index, or stroke work index.

Conclusions:

• Sublingual ISD provides transient but beneficial hemodynamic effects in patients with acute and chronic CHF.
• The primary benefit observed is a reduction in pulmonary capillary wedge pressure, indicating improved left ventricular filling pressures.
• The duration of these hemodynamic effects is less than two hours, suggesting its utility for acute symptom relief.